Advancing our ability to predict who is likely to develop depression in response to stress holds 7 great potential in reducing the burden of the disorder. Large-scale genome-wide association 8 studies (GWAS) of depression have, for the first time, provided a basis for meaningful 9 depression polygenic risk score construction (MDD-PRS). The Intern Health Study utilizes the 10 predictable and large increase in depression with physician training stress to identify predictors 11 of depression. Applying the MDD-PRS derived from the PGC2/23andMe GWAS to 5,227 12 training physicians, we found that MDD-PRS predicted depression under training stress 13 (beta=0.082, p=2.1x10 -12 ) and that MDD-PRS was significantly more strongly associated with 14 depression under stress than at baseline (MDD-PRS x stress interaction -beta=0.029, p=0.02). 15
Introduction 23
According to the World Health Organization, depression is the leading cause of disease-24 associated disability in the world 1 . As current treatments for depression only result in remission 25 in a minority of cases and new treatments have been slow to emerge, the burden of depression, 26
including suicide, has continued to grow. 27
In populations at high risk, prevention of depression may be an effective strategy. The U.S. 28 National Academy of Medicine has highlighted the need to develop, evaluate, and implement 29 prevention interventions for depression and other mental, emotional, and behavioral disorders 2 30 3 . However, our current ability to predict those most at risk for depression is limited. 31
Genetic variation accounts for 30-40% of the population variation in unipolar depression risk 4 . 32
In the past few years, genome-wide association studies have, for the first time, identified a 33 substantial number of variants associated with depression 5 6 . However, no individual variants of 34 moderate to large effect have emerged, with evidence indicating that risk for depression is 35 distributed widely across genome 7 . Because the effect size of identified depression variants is 36 modest, any individual polymorphism has limited utility for risk prediction. Polygenic risk scores 37 (PRS) provide a mechanism for aggregating the cumulative impact of common polymorphisms 38 by summing the number of risk variant alleles in each individual weighted by the impact of each 39 allele on risk of disease. In other disease phenotypes, PRS has shown utility in predicting 40 disease. For instance, the PRS for cardiovascular disease substantially improves risk prediction 41 for disease beyond known risk factors 8 . 42 Prospective cohort studies are critical to evaluating the predictive power of PRS 9 . With life 43 stress accounting for 30-40% of the population variation in unipolar depression risk 10 and 44 approximately 80% of depressive episodes are preceded by a major stressor 11 , a promising 45 strategy is assess depression PRS (MDD-PRS) to predict the development of depression under stress. However, the unpredictable nature of stress makes prospective studies of depression difficult. The first year of professional physician training, medical internship, is an unusual 48 situation where the onset of stress can be reliably predicted. The prevalence of major 49 depression increases 5-6 fold during internship, with a series of psychological and demographic 50 factors predicting the development of depression during internship stress 12 13 . Here, we utilize 51 internship to assess the predictive power of MDD-PRS for depression under stress. 52 Results 53 5,227 medical interns of European ancestry from the Intern Health Study were included for 54 analysis. This sample consisted of 50.3% women and a mean age of 27.6 years. We measured 55 depressive symptoms using the PHQ-9 questionnaire before internship year started (baseline) 56 and every three months during the stressful internship year. Included participants completed the 57 baseline survey and at least one quarterly survey (average number of follow up visits was 3.46, 58 SD = 0.90). The participants had a mean PHQ-9 score of 2.5 (SD = 2.9) at baseline and 5.6 (SD 59 = 3.8) during internship. 3.4% of the subjects met PHQ depression criteria (PHQ-9 score >= 10) 60 at baseline, with the percentage increasing to 33.2% during internship (Table 1) . 61
Association of MDD-PRS with PHQ-9 depressive symptom score 62 We used the summary statistics derived from the most recent Major Depressive Disorder (MDD) 63 GWAS, a meta-analysis of the Psychiatric Genomics Consortium (PGC) MDD phase 2 and 64 23andMe, Inc., a personal genetics company 7 , to calculate the MDD polygenic risk score 65 (MDD-PRS) in our sample, including all genotyped common SNPs in the MDD-PRS calculation. 66
The standardized MDD-PRS in intern subjects had a near-normal distribution ( Figure 1 ). 67
To compare the predictive power of MDD-PRS on depression at baseline and during internship 68 stress, we assessed the association between MDD-PRS and inverse-normalized PHQ-9 score under both conditions. After adjustment for age, sex and top 10 genotype-based PCs, one SD 70 increase of MDD-PRS was associated with 0.052 higher PHQ-9 score at baseline (p = 1.7 x 10 -4 ) 71 and 0.082 higher PHQ-9 score during internship (p = 2.1 x 10 -12 ) (Table 2, Figure 2a ,b left plots). 72
With both baseline and internship PHQ-9 scores included in the model, we found a significant 73 interaction between MDD-PRS and internship stress status on PHQ-9 depressive symptom 74 score (beta = 0.029, p = 0.023), indicating that the effect of MDD-PRS on PHQ-9 score was 75 greater under internship stress than at baseline (Table 2) . 76
To test the robustness of our findings to the set of variants used to calculate MDD-PRS, we also 77 calculated MDD-PRS using LD pruned-imputed common SNPs. We observed slightly 78 attenuated but significant associations between MDD-PRS and PHQ-9, both at baseline (beta = 79 0.042, p = 3.0 x 10 -3 ) and during internship (beta = 0.070, p = 4.3 x 10 -9 ) ( Supplementary Table  80 1). 81
In addition to the quantitative PHQ score, we also utilized PHQ depression diagnosis as an 82 outcome measure. In a logistic regression, we found no significant association between MDD-83 PRS and depression diagnosis at baseline (OR = 0.99, p = 0.88). In contrast, MDD-PRS was 84 significantly associated with depression diagnosis during internship (OR = 1.17, p = 2.0 x 10 -7 ). 85
Parallel to the findings with PHQ-9 score, there was a significant interaction between MDD-PRS 86 and internship status on PHQ depression diagnosis (OR = 1.29, p = 0.019) indicating the effect 87 of MDD-PRS on depression prevalence was greater during internship than baseline. 88
Because the PGC/23andMe GWAS meta-analysis results were generated using European 89 ancestry individuals, we restricted our main MDD-PRS analysis to the European ancestry 90 subjects from our sample 14 . To explore the predictive ability of European ancestry-based MDD-91 MDD-PRS and PHQ-9 scores in either the East Asian group (baseline beta = -0.011, p = 0.77; 95 during internship beta = 0.012, p = 0.69) or the South Asian group (baseline beta = 0.028, p = 96 0.50; internship beta = 4.1 x 10 -4 , p = 0.99). 97
Mediation of the association between MDD-PRS and PHQ-9 depressive 98 symptom score by known risk factors 99 We conducted mediation analysis to quantify the proportion of the association mediated by 100 three risk factors -neuroticism, personal history of depression and a stress early family 101 environment -previously demonstrated to predict depression in both the general population, and 102 training physicians, specifically 12 . To capture the joint contributions of the three known 103 depression risk, we performed principal component analysis and used the first principal 104 component in our analysis (known risk factor-based PC). The contributions of neuroticism, 105 personal history of depression, and early family environment in the first principal component 106 were 39%, 36% and 24% respectively ( Figure 2c ). The known risk factor-based PC explained 107 85.64% of the association between MDD-PRS and PHQ-9 score at baseline but only 55.40% 108 during internship (Table 3, have several-fold higher risk of disease compared to other individuals 8 . In order to assess if either extreme tail of the PRS distribution in our sample more effectively differentiated resilience versus susceptibility to depression during internship stress, we followed the approach of Khera 118 and colleagues and divided our subjects into 40 quantiles from low to high MDD-PRS, each with 119 2.5% of the sample (n=131). To quantitatively assess for a difference in depression risk prediction power between the lowest 126 and highest tail, we serially dichotomized the sample using different MDD-PRS percentile 127 cutpoints and compared the proportion of individuals with depression in the subjects above and 128 below each of the cutpoints. For instance, subjects in the lowest 5% MDD-PRS distribution (low 129 tail; n = 262) had lower rates of PHQ depression during internship (21.8%) compared to the 130 remaining sample (33.8%) (OR = 0.54, 95%CI = 0.40 -0.74, p = 3.7 x 10 -5 ). In contrast, 131 depression proportion of subjects with MDD-PRS scores in the top 5% (high tail; 36.8%) did not 132 differ significantly from depression proportion of the remaining sample (33.0%; OR = 1.2, p = 133 0.18). Using a permutation test, we assessed if the odds ratio (OR) of the depressed subject for 134 one tail was greater than the OR for the other tail (the reference sample for each OR being the 135 subset of participants with lower MDD-PRS). For the 5% cutpoint, we found the low tail had a 136 significantly larger OR than the high tail (p = 0.024, Table 4a ). Similarly, using the PHQ-9 137 depressive symptom score, we found the test statistic for the low tail was significantly larger 138 than that for the high tail (p = 0.038, Table 4b ). These results indicate the lower 5% of the MDD-139 PRS distribution better differentiates depression risk and resilience compared to the upper 5% 140 of the distribution. the proportion depression between the low MDD-PRS group and the remaining sample 143 remained significant (for lower tail cutpoints at 10% (p = 1.6 x 10 -5 ) and 25% (p = .003)) ( Tables  144   4a) . The differences in the depression proportion between the high MDD-PRS group and the 145 remaining sample were also significant (for upper tail cutpoints at 10% (p = .003) and 25% (p = 146 3.7 x10 -4 )) ( Table 4a ). The bottom OR and top OR were not significantly different for the 10% or 147 the 25% cutpoint. We saw a similar pattern for PHQ-9 score (Table 4b) prospective cohort design to demonstrate that MDD-PRS is a significant predictor of future 152 depression. Further, we find evidence that the association between MDD-PRS and depression 153 is stronger in the presence of stress and that the additional predictive power of MDD-PRS under 154 stress is largely independent of known risk factors for depression. Finally, we find that low MDD-155 PRS scores may have particular utility to identify individuals highly resilient to stress. 156
Our finding that MDD-PRS associates with depression during internship stress provides empiric 157 evidence that the cumulative impact of common polymorphisms can produce meaningful risk 158 prediction for depression. We find that individuals in lowest 2.5% of the PRS distribution in our 159 sample have half the risk of developing depression compared to the rest of the sample. The 160 predictive power of MDD-PRS will likely continue to improve with increasingly larger discovery 161 GWAS studies. Based on the improving prediction profiles, individuals could be stratified into 162 different strata of risk for transition to depression 15 , with intensive prevention strategies targeted 163 to high-risk individuals. For instance, in the population of training physicians, web-based CBT has been shown to be effective in the prevention of depression and suicidal ideation and could 165 be targeted for prevention 16 19 , interns indicated whether, during the 232 previous 2 weeks, the symptom had bothered them "not at all," "several days," "more than half 233 the days," or "nearly every day." Each item yields a score of 0 to 3, so that the total score 234 ranges from 0 to 27. A score of 10 or greater on the PHQ-9 was defined as PHQ depression, which has a sensitivity of 93% and a specificity of 88% for the diagnosis of major depressive disorder 20 . Diagnostic validity of the PHQ-9 is comparable with clinician-administered 237 assessments 21 . 238 One to two months prior to internship, subjects completed an online baseline survey, assessing 239 PHQ-9 depressive symptoms, neuroticism (NEO-Five Factor Inventory 22 ), personal history of 240 depression (self-reported yes/no), and early family environment (Risky Families Questionnaire 241 23 ), along with demographic information. We then contacted the participants via email at months 242 3, 6, 9 and 12 of their internship year and asked them to complete online quarterly surveys 243 assessing PHQ-9 depressive symptoms and additional information about their internship 244 experience. All surveys were conducted through a secure online website designed to maintain 245 confidentiality, with subjects identified only by numeric IDs. No links between the identification 246 number and the subjects' identities were maintained. Subjects who completed baseline survey 247 and at least one quarterly survey were included in the analysis, accounting for 86.08% of the 248 total enrolled subjects. 249
Genotyping and imputation 250 We collected DNA from subjects using DNA Genotek Oragene Mailable Tube (OGR-500) 24 251 through the mail. DNA (n = 9,611) was extracted and genotyped on Illumina Infinium 252 CoreExome-24 v1.0 or v1.1 Chip, containing 571,054 and 588,628 SNPs, respectively. 253
Samples with call rate < 99% (n = 179) or with a sex mismatch between genotype data and 254 reported data (n = 129) were excluded. For 539 duplicated samples, the sample with higher call 255 rate was selected. SNPs were excluded if: on non-autosomal chromosomes, call rate < 0.98 256 (after sample removal), or MAF < 0.005. Genotype data from v1.0 Chips and v1.1 Chips were 257 then merged and subject duplication was again checked and 11 more duplicates removed. variants, pairwise r 2 threshold 0.5) which yielded 202,235 SNPs for principal components 261 analysis (PCA) of genotype data using all samples (PLINK version1.9 25 ). We defined European 262 ancestry samples using the following steps. We plotted the first two PC's for self-reported 263
European ancestry samples. Based on the plot, to reduce genetic heterogeneity, we included 264 samples that fell within mean PC1 3SD and and mean PC2 6SD. We additionally included 265 subjects who did not report ethnicity but whose PC1 and PC2 values were within the range 266 defined above. From this set of European ancestry samples (n = 5,710), we excluded SNPs 267 with Hardy-Weinberg equilibrium P < 10 -6 , leaving 325,249 genotyped SNPs. We defined East 268
Asian ancestry (n = 816) and South Asian ancestry (n = 595) samples with the same procedure, 269 except for East Asian, the sample inclusion range was mean PC1 3SD and and mean 270 PC2 4.5SD, and for South Asian, it was mean PC1 2.5SD and and mean PC2 3.5SD 271 ( Supplementary Figure 1) . 272
We performed genotype imputation on the Michigan Imputation Server using Minimac3 to phase Association of MDD-PRS with PHQ-9 depressive symptom score 296 Internship PHQ-9 depressive symptom score was calculated by averaging PHQ-9 score across 297 all available internship assessment. Subjects who reported a PHQ-9 score greater than or equal 298 to 10 in at least one internship assessment were classified as meeting criteria for PHQ 299 depression during internship. We used linear regression to test for association of MDD-PRS 300 with inverse normalized baseline PHQ-9 or internship PHQ-9, adjusting for age, sex and the top 301 10 principal components of genotype data. We also used logistic regression to assess the 302 association of MDD-PRS with baseline and internship PHQ depression. 303
To assess whether the effect size of MDD-PRS associating with PHQ-9 or PHQ depression was 304 significantly different at baseline and during internship, we used a linear mixed model or a logistic mixed model to assess the interaction effect between MDD-PRS and internship status, adjusting for main effect of MDD-PRS, internship status, age, sex and the top 10 principal 307 components of genotype data. We included a random intercept term to account for correlation 308 between the repeated measurements within subjects. 309
Relationship between MDD-PRS and known risk factors of depression 310
In a separate analysis, we jointly included the three know risk factors (personal depression 311 history, neuroticism score and early family environment) 12 as covariates in the models above. 312
Continuous variables including neuroticism score and early family environment were scaled to 313 have a SD of 1. Where Y is the outcome (inverse normalized baseline or internship PHQ-9) and P is the 321 predictor (MDD-PRS). M is the mediator, either one of the known risk factors or the first principal 322 component from a principal component analysis of the three known risk factors. α i (i=1,2,3) and 323 ε i (i=1,2,3) represent the intercepts and errors, respectively. Coefficient β 1 represents the total 324 effect of the MDD-PRS on PHQ-9, β 2 represents the effect of MDD-PRS on a known risk factor, 325 β 3 represents the direct effect of MDD-PRS on PHQ-9 (defined the effect of MDD-PRS that is 326 not accounted for by a known risk factor). γ represents the effect of a known risk factor on PHQ-327 9. β 2 γ represents the indirect effect of MDD-PRS on PHQ-9 that is mediated by the known risk is the proportion of the total MDR-PRS effect that is mediated by the known risk factor. To 330 assess the significance of the mediated proportion, we performed 100,000 non-parametric 331 bootstraps to estimate 95% confidence interval and p-value of the mediated proportion test for 332 significant mediation, tested under the null hypothesis of the mediated proportion being zero. 333
Differences in PHQ-9 depressive symptoms or PHQ depression proportion by MDD- 334 
PRS percentile cutpoint 335
To test for the ability of higher or lower MDD-PRS to predict different levels of risk of PHQ 336 depression (raw PHQ-9 score >= 10) or PHQ-9, we divided the sample based on an MDD-PRS 337 percentile cut point, including 2.5, 5, 10, 25, 75, 90, 95 and 97.5 percentile cutpoints. At each 338 MDD-PRS percentile cutpoint, we separate the subjects into two subgroups, one is the tail 339 subgroup whose MDD-PRS percentile is lower (for cutpoints<50) or higher (for cutpoints>50) 340 than the cutpoint, the other is the remaining of the subjects. Then we compared the proportion 341 of individuals with PHQ depression in the tail subgroup and the remaining subgroup using a 342
Fisher's exact test. We also compared the PHQ-9 score in the tail subgroup and the remaining 343 subgroup using a two sample t-test. For pairs of cut points that defined the same size of the 344 sample at the low and high tails of the distribution (for example 5% and 95%), we used a 345 permutation test to assess if the magnitude of the difference between the higher and lower 346 MDD-PRS subgroups differed between the two cutpoints. Specifically, in each of 10,000 347 permutations, we permuted the MDD-PRS scores for all subjects, reran the Fisher's exact tests 348 and t-tests for a given pair of cutpoints, and calculated the ratio of the odds ratios ((1/low tail OR) 349 / high tail OR) and the difference of two t-tests statistics (-t-statistic low tail MDD-PRS-remaining MDD-PRS ) -350 t-statistic high tail MDD-PRS -remaining MDD-PRS ). For each observed ratio of the odd ratios, we estimated 351 the two-sided p-value as the number of permutations with a ratio of odds ratios more extreme 352 than either the observed ratio of the odds ratios or 1/(the observed ratio of odds ratios), divided by the number of permutations. For each difference in two t-tests, we calculated the two-sided 354 p-value as the number of permutations with an abs(difference in two t-tests) > abs(observed 355 difference in the two t-tests), divided by the number of permutations. 356 Data Availability
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